十一烷二酸二甲酯 | 4567-98-0

• 物质功能分类: 分析化学 - 食品安全 - 脂肪酸、脂肪酸甲酯
• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 中文名称: 十一烷二酸二甲酯
• 中文别名: 十一碳二酸二甲酯
• 英文名称: dimethyl undecanedioate
• 英文别名: undecanedioic acid dimethyl ester；dimethyl 1,9-nonanedicarboxylate；dimethyl undecandioate；dimethyl undecadioate；Undecandisaeure-dimethylester
• CAS: 4567-98-0
• 化学式: C₁₃H₂₄O₄
• mdl: MFCD00025899
• 分子量: 244.331
• InChiKey: LADJFIHHYMBJHB-UHFFFAOYSA-N

物化性质

• 熔点：
  17-19 °C
• 沸点：
  123-124 °C/2 mmHg (lit.)
• 密度：
  0.983 g/mL at 20 °C (lit.)
• 闪点：
  109°C
• 保留指数：
  1713;1714;1714;1714

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  17
• 可旋转键数：
  12
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.846
• 拓扑面积：
  52.6
• 氢给体数：
  0
• 氢受体数：
  4

安全信息

• WGK Germany：
  3
• 安全说明：
  S24/25
• 海关编码：
  2917190090
• 储存条件：
  | 室温 |

SDS

---

Section 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE
Product identifiers
Product name : Dimethyl undecanedioate
CAS-No. : 4567-98-0
Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, Manufacture of substances

---

Section 2. HAZARDS IDENTIFICATION
Classification of the substance or mixture
Not a hazardous substance or mixture according to Regulation (EC) No 1272/2008
This substance is not classified as dangerous according to Directive 67/548/EEC.
Label elements
The product does not need to be labelled in accordance with EC directives or respective national laws.
Other hazards - none

---

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
Substances
Formula : C13H24O4
Molecular Weight : 244,33 g/mol

---

Section 4. FIRST AID MEASURES
Description of first aid measures
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration.
In case of skin contact
Wash off with soap and plenty of water.
In case of eye contact
Flush eyes with water as a precaution.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water.
Most important symptoms and effects, both acute and delayed
Indication of any immediate medical attention and special treatment needed
no data available

---

Section 5. FIREFIGHTING MEASURES
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

---

Section 6. ACCIDENTAL RELEASE MEASURES
Personal precautions, protective equipment and emergency procedures
Avoid breathing vapors, mist or gas.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Keep in suitable, closed containers for disposal.
Reference to other sections
For disposal see section 13.

---

Section 7. HANDLING AND STORAGE
Precautions for safe handling
Normal measures for preventive fire protection.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Containers which are
opened must be carefully resealed and kept upright to prevent leakage.
Specific end uses
no data available

---

Section 8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
General industrial hygiene practice.
Personal protective equipment
Eye/face protection
Use equipment for eye protection tested and approved under appropriate government standards
such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
impervious clothing, The type of protective equipment must be selected according to the
concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
Respiratory protection not required. For nuisance exposures use type OV/AG (US) or type ABEK
(EU EN 14387) respirator cartridges. Use respirators and components tested and approved under
appropriate government standards such as NIOSH (US) or CEN (EU).

---

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
Information on basic physical and chemical properties
a) Appearance Form: liquid, clear
Colour: colourless
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing Melting point/range: 17 - 19 °C
point
f) Initial boiling point and 123 - 124 °C at 3 hPa - lit.
boiling range
g) Flash point 109,00 °C - closed cup
h) Evaporation rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower no data available
flammability or
explosive limits
k) Vapour pressure no data available
l) Vapour density no data available
m) Relative density 0,983 g/cm3 at 20 °C
n) Water solubility no data available
o) Partition coefficient: n- no data available
octanol/water
p) Autoignition no data available
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

---

Section 10. STABILITY AND REACTIVITY
Reactivity
no data available
Chemical stability
no data available
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
Other decomposition products - no data available

---

Section 11. TOXICOLOGICAL INFORMATION
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitization
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Potential health effects
Inhalation May be harmful if inhaled. May cause respiratory tract irritation.
Ingestion May be harmful if swallowed.
Skin May be harmful if absorbed through skin. May cause skin irritation.
Eyes May cause eye irritation.
Additional Information
RTECS: Not available

---

Section 12. ECOLOGICAL INFORMATION
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
no data available
Other adverse effects
no data available

---

Section 13. DISPOSAL CONSIDERATIONS
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company.
Contaminated packaging
Dispose of as unused product.

---

Section 14. TRANSPORT INFORMATION
UN number
ADR/RID: - IMDG: - IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA: Not dangerous goods
Transport hazard class(es)
ADR/RID: - IMDG: - IATA: -
Packaging group
ADR/RID: - IMDG: - IATA: -
Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
Special precautions for user
no data available

---

Section 15. REGULATORY INFORMATION
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
Safety, health and environmental regulations/legislation specific for the substance or mixture
no data available
Chemical Safety Assessment
no data available

---

Section 16. OTHER INFORMATION
Further information
Copyright 2012 Co. LLC. License granted to make unlimited paper copies for internal use
only.
The above information is believed to be correct but does not purport to be all inclusive and shall be
used only as a guide. The information in this document is based on the present state of our knowledge
and is applicable to the product with regard to appropriate safety precautions. It does not represent any
guarantee of the properties of the product. Corporation and its Affiliates shall not be held
liable for any damage resulting from handling or from contact with the above product. See
and/or the reverse side of invoice or packing slip for additional terms and conditions of sale.

反应信息

• 作为反应物：
  描述：

  十一烷二酸二甲酯 在 barium dihydroxide 作用下， 生成 11-甲氧基-11-氧代十一酸
  参考文献：
  名称：

  Durham; McLeod; Cason, Organic Syntheses, 1958, vol. 38, p. 55

  摘要：

  DOI：
• 作为产物：
  描述：

  十一烷二酸 在 硫酸 作用下， 生成 十一烷二酸二甲酯
  参考文献：
  名称：

  Durham; McLeod; Cason, Organic Syntheses, 1958, vol. 38, p. 55

  摘要：

  DOI：

文献信息

• Two-way homologation of aliphatic aldehydes: Both one-carbon shortening and lengthening via the same intermediate
  作者：Jae Won Yoo、Youngran Seo、Jong Beom Park、Young Gyu Kim

  DOI：10.1016/j.tet.2019.130883

  日期：2020.2

  Aliphatic aldehydes can be homologated to both one-carbon shorter and one-carbon longer homologous carbonyl compounds through the 2–4 steps of reactions via the same intermediates, β,γ-unsaturated α-nitrosulfones, prepared from the proline-catalyzed sequential reactions of several aliphatic aldehydes with phenylsulfonylnitromethane. While the oxidative cleavage of the key intermediates gave one-carbon

  脂肪醛可通过相同的中间体β，γ-不饱和α-硝基砜，经脯氨酸催化的连续反应制备的相同中间体，通过2–4个反应，与一碳短和一碳长的同源羰基化合物同源。几种脂肪醛与苯磺酰基硝基甲烷。当关键中间体的氧化裂解得到一碳较少的同源羰基化合物时，相同关键中间体的还原随后被氧化产生了更多一碳的同源羰基化合物。
• Identification and Quantification of Aerosol Polar Oxygenated Compounds Bearing Carboxylic or Hydroxyl Groups. 1. Method Development
  作者：M. Jaoui、T. E. Kleindienst、M. Lewandowski、E. O. Edney

  DOI：10.1021/ac049919h

  日期：2004.8.1

  In this study, a new analytical technique was developed for the identification and quantification of multifunctional compounds containing simultaneously at least one hydroxyl or one carboxylic group, or both. This technique is based on derivatizing first the carboxylic group(s) of the multifunctional compound using an alcohol (e.g., methanol, 1-butanol) in the presence of a relatively strong Lewis acid (BF3) as a catalyst. This esterification reaction quickly and quantitatively converts carboxylic acids to their ester forms. The second step is based on silylation of the ester compounds using bis(trimethylsilyl) trifluoroacetamide (BSTFA) as the derivatizing agent. For compounds bearing ketone groups in addition to carboxylic and hydroxyl groups, a third step was used based on PFBHA derivatization of the carbonyls. Different parameters including temperature, reaction time, and effect due to artifacts were optimized. A GC/MS in EI and in methane-CI mode was used for the analysis of these compounds. The new approach was tested on a number of multifunctional compounds. The interpretation of their EI (70 eV) and CI mass spectra shows that critical information is gained leading to unambiguous identification of unknown compounds. For example, when derivatized only with BF3−methanol, their mass spectra comprise primary ions at m/z M•+ + 1, M•+ + 29, and M•+ − 31 for compounds bearing only carboxylic groups and M•+ + 1, M•+ + 29, M•+ − 31, and M+. − 17 for those bearing hydroxyl and carboxylic groups. However, when a second derivatization (BSTFA) was used, compounds bearing hydroxyl and carboxylic groups simultaneously show, in addition to the ions observed before, ions at m/z M•+ + 73, M•+ − 15, M•+ − 59, M•+ − 75, M•+ − 89, and 73. To the best of our knowledge, this technique describes systematically for the first time a method for identifying multifunctional oxygenated compounds containing simultaneously one or more hydroxyl and carboxylic acid groups.

  在本研究中，开发了一种新的分析技术，用于鉴定和定量含有至少一个羟基或一个羧基或两者的多官能团化合物。该技术基于首先使用醇（例如甲醇、1-丁醇）在相对较强的路易斯酸（BF3）催化下对多官能团化合物的羧基进行衍生化。这种酯化反应迅速且定量地将羧酸转化为酯形式。第二步是使用双(三甲基硅基)三氟乙酰胺（BSTFA）作为衍生化剂对酯化合物进行硅烷化。对于除羧基和羟基外还含有酮基的化合物，采用了基于PFBHA对羰基进行衍生化的第三步。优化了包括温度、反应时间和因人工产物引起的影响等多个参数。使用电子轰击源（EI）和甲烷化学电离（CI）模式的气相色谱/质谱法（GC/MS）分析了这些化合物。对多种多官能团化合物测试了新方法。对其EI（70 eV）和CI质谱的解释表明，获得了关键信息，从而能够明确鉴定未知化合物。例如，仅通过 −甲醇衍生化时，它们的质谱包含仅含有羧基的化合物的离子m/z M•+ + 1、M•+ + 29和M•+ − 31，以及同时含有羟基和羧基的化合物的离子m/z M•+ + 1、M•+ + 29、M•+ − 31和M•+ − 17。然而，当使用第二步衍生化（BSTFA）时，同时含有羟基和羧基的化合物除了之前观察到的离子外，还显示出m/z M•+ + 73、M•+ − 15、M•+ − 59、M•+ − 75、M•+ − 89和73的离子。据我们所知，这项技术首次系统地描述了一种鉴定同时含有一个或多个羟基和羧酸基团的多官能团含氧化合物的方法。
• Efficient Palladium‐Catalyzed Carbonylation of 1,3‐Dienes: Selective Synthesis of Adipates and Other Aliphatic Diesters
  作者：Ji Yang、Jiawang Liu、Yao Ge、Weiheng Huang、Francesco Ferretti、Helfried Neumann、Haijun Jiao、Robert Franke、Ralf Jackstell、Matthias Beller

  DOI：10.1002/anie.202015329

  日期：2021.4.19

  The dicarbonylation of 1,3‐butadiene to adipic acid derivatives offers the potential for a more cost‐efficient and environmentally benign industrial process. However, the complex reaction network of regioisomeric carbonylation and isomerization pathways, make a selective and direct transformation particularly difficult. Here, we report surprising solvent effects on this palladium‐catalysed process

  将1,3-丁二烯二羰基化为己二酸衍生物可为更具成本效益和环境友好的工业生产提供潜力。然而，区域异构体羰基化和异构化途径的复杂反应网络使得选择性和直接转化特别困难。在这里，我们报道了在存在1,2-双-二叔丁基膦膦-二甲苯（d t bpx）配体的情况下，钯催化的这一过程产生了令人惊讶的溶剂影响，这些配体允许由1,3-丁二烯，碳形成己二酸酯二酯。一氧化碳和甲醇，在可扩展条件下具有97％的选择性和100％的原子经济性。在最佳条件下，可以以高至极好的收率获得各种1,2-和1,3-二烯的二酯和三酯。
• Methods for synthesizing ether compounds and intermediates therefor
  申请人：Esperion Therapeutics, Inc.

  公开号：US06410802B1

  公开（公告）日：2002-06-25

  The present invention relates to novel ether compounds, compositions comprising ether compounds, and methods useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders comprising administering a composition comprising an ether compound. The compounds, compositions, and methods of the invention are also useful for treating and preventing Alzheimer's Disease, Syndrome X, peroxisome proliferator activated receptor-related disorders, septicemia, thrombotic disorders, obesity, pancreatitis, hypertension, renal disease, cancer, inflammation, and impotence. In certain embodiments, the compounds, compositions, and methods of the invention are useful in combination therapy with other therapeutics, such as hypocholesterolemic and hypoglycemic agents.

  本发明涉及新型醚化合物、含有醚化合物的组合物，以及用于治疗和预防心血管疾病、血脂异常、蛋白异常和葡萄糖代谢紊乱的方法，包括给予含有醚化合物的组合物。该发明的化合物、组合物和方法还适用于治疗和预防阿尔茨海默病、X综合症、过氧化物酶体增殖物激活受体相关疾病、败血症、血栓性疾病、肥胖、胰腺炎、高血压、肾脏疾病、癌症、炎症和阳痿。在某些实施方式中，该发明的化合物、组合物和方法可与其他治疗药物联合治疗，如降胆固醇和降血糖药物。
• Synthesis of 2,4-Furanophanes by Palladium-Catalyzed Macrocyclization Reactions of 1,n-Diallenyl Diketones
  作者：A. Stephen K. Hashmi、Lothar Schwarz、Michael Bolte

  DOI：10.1002/ejoc.200300792

  日期：2004.5

  The 1,n-diallenyl diketones 8a−j were prepared and subjected to reactions with the [PdCl2(MeCN)2] catalyst. Upon decreasing the length of the bridge between the allenyl ketone units, first we obtained the (E) isomer 10 as the macrocyclic product and then the (Z) isomer 11 accompanied by the exocyclic double bond isomer 12. In all cases, the open-chained 1,n-difuryl alkanes were isolated as side-products

  制备 1,n-二烯基二酮 8a-j 并使其与 [PdCl2(MeCN)2] 催化剂反应。在减少丙二烯基酮单元之间的桥的长度后，首先我们得到 (E) 异构体 10 作为大环产物，然后得到 (Z) 异构体 11 和环外双键异构体 12。在所有情况下，开环-链状 1,n-二呋喃烷烃作为副产物被分离出来。具有更长桥连和醚官能团的二烯基二酮 19 和 24 的类似制备和转化产生了 20 至 52 元大环 21a、21b、26a 和 26b，仅具有预期的 (E) 构型双键。呋喃衍生物的闭环，在其 2-和 4-位的取代基中具有乙烯基，通过 Ru 催化的烯烃复分解反应生成相关产物，其产率类似于 Pd 催化的大环化，但提供了两种双键异构体的混合物。(© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2004)

表征谱图